Skip to main content
Spero Cataland, MD, Hematology, Columbus, OH

Spero Rick Cataland MD

Hematology•Columbus, OH

Professor of Medicine, Ohio State University

Join to View Full Profile

  • 460 W 10th AveColumbus, OH 43210

  • Phone+1 614-293-8619

  • Fax+1 614-293-6420

Dr. Cataland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Cataland's Full ProfileAlready have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 1994 - 1997
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1994

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1995 - 2027
  • IL State Medical License
    IL State Medical License 1997 - 2002
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Role of ADAMTS13 Testing in the Diagnosis and Management of Thrombotic Microangiopathies and Thrombosis  
    Spero R Cataland, Camila Masias, Blood

Abstracts/Posters

  • Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen
    Spero Cataland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura
    Spero Cataland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Impact of Residual Effects and Complications of Thrombotic Thrombocytopenic Purpura (TTP) on Daily Living: A Qualitative Study
    Spero Cataland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Adult Clinical Non-Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Aware of the Rare: Diagnosing and Treating Immune-Mediated Hematologic Disorders 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Cost Is the Main Hurdle to Broad Use of Caplacizumab for TTP
    Cost Is the Main Hurdle to Broad Use of Caplacizumab for TTPDecember 7th, 2020
  • Ultomiris Receives Approval for Atypical Hemolytic Uremic Syndrome
    Ultomiris Receives Approval for Atypical Hemolytic Uremic SyndromeOctober 22nd, 2019
  • Alexion Receives FDA Approval for ULTOMIRIS® (Ravulizumab-Cwvz) for Atypical Hemolytic Uremic Syndrome (aHUS)
    Alexion Receives FDA Approval for ULTOMIRIS® (Ravulizumab-Cwvz) for Atypical Hemolytic Uremic Syndrome (aHUS)October 18th, 2019

Grant Support

  • Initiation of a cohort to define pathogenic Mechanisms, Precision diagnosis And Complications of Thrombotic Microangiopathies: The IMPACT StudyJOHNS HOPKINS UNIVERSITY2025–2030

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Spero Cataland, Dr. Spero Cataland, MD, Dr. S Cataland, Dr. Spero Rick Cataland